4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-24-051264
Director sold 37,161 shares at $6.19 ($229,956)
- Director acquired 50,001 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jaksch Frank L Jr · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-13 | Exercise or conversion : show line 1 in the form | +50,001 | $3.66 | $183,004 | 281,340 | D |
| 2024-12-13 | Sale : show line 2 in the form | −37,161 | $6.19 | $229,956 | 244,179 | D |
| Open-market sales · 37,161 sh · avg $6.19 · $229,956 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-13 | Exercise or conversion : show line 3 in the form Employee Stock Options (right to buy) | −50,001 | 0 | D |
Loading xslF345X05/wk-form4_1734135129.xml…